Jane S. Ricciuti, RPh, MS


April 22, 2003

In This Article

Counterterrorism Agents

Reactive Skin Decontamination Lotion

Manufacturer: O'Dell Engineering Ltd/E-Z-EM Canada Inc

Drug Approval Classification: Original New Drug Application (Approval Date: 03/28/03)

Indication: Reactive Skin Decontamination Lotion (RSDL) is approved for use by the US military. RSDL is a liquid decontamination lotion intended to remove or neutralize chemical warfare agents and T-2 fungal toxin from the skin.

Clinical Summary: The lotion is impregnated in a sponge pad packaged as a single unit in a heat-sealed foil pouch. When exposed to chemical warfare agents, the user wipes the exposed skin with the lotion. The lotion removes the agents or the T-2 toxin and also reacts with the chemical agents, rapidly neutralizing them so they are nontoxic.

Reactive Skin Decontamination Lotion (RSDL) FDA Release


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.